This Article Full Text Full Text (PDF) All Versions of this Article: 35/6/e156    most recent 01.STR.0000126609.18735.bev1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Dziedzic, T. Articles by Szczudlik, A. Search for Related Content PubMed PubMed Citation Articles by Dziedzic, T. Articles by Szczudlik, A. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Stroke Related Collections Acute Cerebral Infarction

(Stroke. 2004;35:e156.)
© 2004 American Heart Association, Inc.

Research Reports

Serum Albumin Level as a Predictor of Ischemic Stroke Outcome

From Department of Neurology, Jagiellonian University, Krakow, Poland.

Correspondence to Dr Tomasz Dziedzic, Dept of Neurology, Jagiellonian University, Botaniczna 3, 31-503 Krakow, Poland. E-mail dziedzictom{at}mediclub.pl

Background and Purpose— Animal studies showed that human albumin therapy is strongly neuroprotective in focal ischemia. The aim of our study was to determine if relatively high serum albumin level is associated with decreased risk of poor outcome in ischemic stroke patients.

Methods— Seven hundred fifty-nine consecutive patients with acute ischemic stroke were included. Functional outcome was measured 3 months after stroke using modified Rankin Scale (mRS). Poor outcome was defined as mRS >3 or death. Serum albumin level was measured within 36 hours after stroke onset.

Results— Patients with poor outcome had significantly lower serum albumin level than patients with nonpoor outcome (34.1±7.4 versus 36.8±6.7 g/L). On logistic regression analysis, serum albumin level remained independent predictor of poor outcome (odds ratio [OR]: 0.43; 95% confidence interval [CI]: 0.26 to 0.70).

Conclusions— Relatively high serum albumin level in acute stroke patients decreases the risk of poor outcome.

Key Words: stroke • cerebral ischemia • outcome • albumins